Consistently, HCC specimens with ESRP2 silencing showed higher methylation density compared to non‐tumor tissues (Figure 1G), supporting that promoter hypermethylation might be the major cause of ESRP2 downregulation in HCC. The gene discussed is ESRP2; the disease is neoplasm.